Tissue mimetic 3D scaffold for breast tumor-derived organoid culture toward personalized chemotherapy
[Display omitted] •Porous scaffolds of polycaprolcatone (PCL) were prepared by particulate leaching.•Cancer associated fibroblasts (CAFs) were cultured in scaffolds to deposit proteins.•Protein coated PCL hybrid scaffolds were prepared by decellularization of CAFs.•Primary breast cancer cells prolif...
Saved in:
Published in: | Colloids and surfaces, B, Biointerfaces Vol. 180; pp. 334 - 343 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Netherlands
Elsevier B.V
01-08-2019
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | [Display omitted]
•Porous scaffolds of polycaprolcatone (PCL) were prepared by particulate leaching.•Cancer associated fibroblasts (CAFs) were cultured in scaffolds to deposit proteins.•Protein coated PCL hybrid scaffolds were prepared by decellularization of CAFs.•Primary breast cancer cells proliferated on the scaffolds to form tumoroids.•Patient-specific response to cancer drugs were measured using the tumoroid cultures.
Breast cancer cell lines lose the inherent gene expression profiles of their source tumor and when cultured as monolayers (two-dimensional) are unable to represent patient tumors. Thus, we engineered a biochemico- and mechano-mimetic three-dimensional (3D) culture platform for primary breast cancer cells by decellularizing cancer-associated fibroblasts (CAFs) cultured on 3D macroporous polymer scaffolds to recapitulate tumor behavior and drug response more realistically. The presence of the CAF-derived extracellular matrix deposited on the polycaprolactone scaffold promoted cell attachment and viability, which is ascribed to higher levels of phosphorylated Focal Adhesion Kinase that mediates cell attachment via integrins. Single cells from primary breast cancers self-organized into tumoroids on prolonged culture. Response of the tumoroids to two chemotherapeutic drugs, doxorubicin and mitoxanthrone, varied significantly across patient samples. This model could be used as an ex vivo platform to culture primary cells toward developing effective and personalized chemotherapy regimens. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0927-7765 1873-4367 |
DOI: | 10.1016/j.colsurfb.2019.04.056 |